Search

Chat With Us

    LICAMM Vascular Smooth Muscle Cell Orai1 and vascular disease
    Go to University of Leeds
    University of Leeds

    LICAMM Vascular Smooth Muscle Cell Orai1 and vascular disease

    University of Leeds

    University of Leeds

    flag

    United Kingdom, Leeds

    University RankQS Ranking
    83

    Key Facts

    Program Level

    PhD (Philosophy Doctorate)

    Study Type

    Full Time

    Delivery

    On Campus

    Campuses

    Main Site

    Program Language

    English

    Start & Deadlines

    Next Intake Deadlines
    Apply to this program

    Go to the official application for the university

    Duration 4 year(s)

    LICAMM Vascular Smooth Muscle Cell Orai1 and vascular disease

    About

    Summary

    Orai1 is a highly selective calcium permeable ion channel which is expressed in vascular smooth muscle cells (VSMCs), the main cellular component of the vessel wall. It is already established as an important driver of pathological vascular remodeling in cardiovascular diseases and a potential novel therapeutic target (1). We have previously shown that inhibition of Orai1 protects the heart from adverse remodeling in the context of pressure overload (2). In our laboratory we have developed VSMC conditional Orai1 knockout mice. In this project we will use these mice and aligned studies in wild-type mice using our novel Orai1 small-molecule inhibitors to explore the role of Orai1 in atherosclerosis and neo-intimal hyperplasia (the driving force behind surgical or endovascular treatment failure) to model human disease with and without metabolic stress. The study will use both dietary and surgical disease models of vascular disease, transgenic mice and CT angiography in our British Heart Foundation funded pre-clinical imaging facility.

    Full description

    References
    1. Shawer H, Norman K, Cheng CW, Foster R, Beech DJ, Bailey MA. ORAI1 Ca 2+ Channel as a Therapeutic Target in Pathological Vascular Remodelling. Front Cell Dev Biol. 2021 Apr 6;9:653812. doi: 10.3389/fcell.2021.653812.
    2. Bartoli F, Bailey MA, Rode B, Mateo P, Antigny F, Bedouet K, Gerbaud P, Gosain R, Plante J, Norman K, Gomez S, Lefebvre F, Rucker-Martin C, Ainscough JFX, Kearney MT, Bruns AF, Shi J, Appleby HL, Young RS, Shawer HM, Debant M, Gomez AM, Beech DJ, Foster R, Benitah JP, Sabourin J. Orai1 Channel Inhibition Preserves Left Ventricular Systolic Function and Normal Ca2+ Handling After Pressure Overload. Circulation. 2020 Jan 21;141(3):199-216. doi: 10.1161/CIRCULATIONAHA.118.038891.

    Requirements

    Entry Requirements

    A degree in biological sciences, dentistry, medicine, midwifery, nursing, psychology or a good honours degree in a subject relevant to the research topic. A Masters degree in a relevant subject area is desirable but not essential.

    English Program Requirements

    Applicants whose first language is not English must provide evidence that their English language is sufficient to meet the specific demands of their study. The Faculty of Medicine and Health minimum requirements in IELTS and TOEFL tests for PhD, MSc, MPhil, MD are: • British Council IELTS - score of 6.5 overall, with no element less than 6.0 • TOEFL iBT - overall score of 92 with the listening and reading element no less than 21, writing element no less than 22 and the speaking element no less than 23.

    Fee Information

    Tuition Fee

    GBP 0 

    Application Fee

    GBP  
    University of Leeds

    LICAMM Vascular Smooth Muscle Cell Orai1 and vascular disease

    University of Leeds

    [object Object]

    United Kingdom,

    Leeds

    Similar Programs

    Other interesting programs for you

    Find More Programs
    Wishlist